Wait-and-see approach `feasible' in AOM

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1275, 2001-01, pp. : 14-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Wait-and-see a winning approach for AOM in more ways than one

By  

Inpharma, Vol. 1, Iss. 1555, 2006-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

The SeeDs Approach: Integrating Fragments into Drug Discovery

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 16, 2007-08 ,pp. : 1568-1581

Bentham Science Publishers

Access to resources Recommend Favorite

Watchful waiting acceptable with provisos in AOM

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 483, 2005-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Frontline rituximab monotherapy induction versus a watch and wait approach for asymptomatic advanced-stage follicular lymphoma: A cost-effectiveness analysis

By Prica Anca   Chan Kelvin   Cheung Matthew  

Cancer, Vol. 121, Iss. 15, 2015-08 ,pp. : 2637-2645

Blackwell Publishing

Access to resources Recommend Favorite

Cancer Vaccines for Hormone/Growth Factor Immune Deprivation:A Feasible Approach for Cancer Treatment

By  

Current Cancer Drug Targets, Vol. 7, Iss. 3, 2007-05 ,pp. : 229-241

Bentham Science Publishers

Access to resources Recommend Favorite